UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Clinical proteomics opens up a new avenue of cancer research

Fujita Medical Journal, 2022, Vol.8(Supplement), pp.8-8

Taguchi, Ayumu

2022

Volltextzugriff (PDF)

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity

Nature communications, 2019-01, Vol.10 (1), p.254-254, Article 254

2019

Volltextzugriff (PDF)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer

International journal of molecular sciences, 2017-03, Vol.18 (3), p.573-573

2017

Volltextzugriff (PDF)

Novel urinary protein biomarker panel for early diagnosis of gastric cancer

British journal of cancer, 2020-11, Vol.123 (11), p.1656-1664

2020

Volltextzugriff (PDF)

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway

Cancer research (Chicago, Ill.), 2017-08, Vol.77 (16), p.4414-4425

2017

Volltextzugriff (PDF)

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

Clinical cancer research, 2021-02, Vol.27 (4), p.1150-1161

2021

Volltextzugriff (PDF)

Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma

Cancer science, 2021-03, Vol.112 (3), p.1225-1234

2021

Volltextzugriff (PDF)

Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers

Molecules (Basel, Switzerland), 2021-02, Vol.26 (4), p.882

2021

Volltextzugriff (PDF)

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

Proceedings of the National Academy of Sciences - PNAS, 2016-03, Vol.113 (11), p.E1555-E1564

2016

Volltextzugriff (PDF)

Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer

Oncogene, 2023-01, Vol.42 (5), p.364-373

2023

Volltextzugriff (PDF)

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.372-379

2019

Volltextzugriff (PDF)

Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma

JNCI : Journal of the National Cancer Institute, 2015-08, Vol.107 (8), p.1

2015

Volltextzugriff (PDF)

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

JNCI : Journal of the National Cancer Institute, 2017-03, Vol.109 (3), p.1

2017

Volltextzugriff (PDF)

miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer

Cancer research (Chicago, Ill.), 2011-10, Vol.71 (19), p.6165-6173

2011

Volltextzugriff (PDF)

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas

JNCI : Journal of the National Cancer Institute, 2022-02, Vol.114 (2), p.290-301

2022

Volltextzugriff (PDF)

Pro–Surfactant Protein B As a Biomarker for Lung Cancer Prediction

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4536-4543

2013

Volltextzugriff (PDF)

Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF‐1α regulator

Cancer science, 2021-04, Vol.112 (4), p.1614-1623

2021

Volltextzugriff (PDF)

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Cancer cell, 2011-09, Vol.20 (3), p.289-299

2011

Volltextzugriff (PDF)

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

Cancer research (Chicago, Ill.), 2007-07, Vol.67 (13), p.6007-6011

2007

Volltextzugriff (PDF)

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2331

2024

Volltextzugriff (PDF)

MDM2 Promoter Polymorphism Is Associated With Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis

Journal of clinical oncology, 2006-09, Vol.24 (27), p.4434-4440

2006

Volltextzugriff (PDF)

Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies

Journal of clinical medicine, 2016-11, Vol.5 (12), p.109

2016

Volltextzugriff (PDF)

Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan

Cancer epidemiology, biomarkers & prevention, 2005-11, Vol.14 (11), p.2487-2493

2005

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(133)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical proteomics opens up a new avenue of cancer research

Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer

Novel urinary protein biomarker panel for early diagnosis of gastric cancer

MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma

Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer

Bioinformatics and Functional Analyses Implicate Potential Roles for EOGT and L-fringe in Pancreatic Cancers

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer

Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma

Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma

miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas

Pro–Surfactant Protein B As a Biomarker for Lung Cancer Prediction

Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF‐1α regulator

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma

MDM2 Promoter Polymorphism Is Associated With Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis

Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies

Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

Suchergebnisse filtern